Inflammatory Biomarkers as Predictors of PONV Following Pediatric Orchiopexy
Recruiting now
Conditions studied: Pediatric Anesthesia, Postoperative Nausea and Vomiting (PONV), Inflammatory Biomarkers
In brief
Orchiopexy is a common surgical procedure for the treatment of cryptorchidism in the pediatric population, with a high incidence of postoperative nausea and vomiting (PONV). Recent evidence suggests that systemic inflammation may contribute to PONV pathogenesis, and preoperative inflammatory biomarkers such as NLR, PLR, SII, MLR, and SIRI could serve as predictive indicators. This prospective observational study aims to evaluate the relationship between these biomarkers and PONV incidence in children undergoing orchiopexy.
Key facts
- Study ID
- NCT07148063
- Run by
- Diskapi Yildirim Beyazit Education and Research Hospital
- People needed
- 170
- Starts
- 2025-09-08
- Expected to finish
- 2026-03-27
- Last updated by the study team
- 2025-09-09
Who can join
Age: 1 and older, up to 8. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients aged between 1 and 8 years
- Patients with ASA physical status I-II
- Patients scheduled for elective orchiopexy
- Obtained written informed consent from parents/guardians
You may not qualify if…
- Patients younger than 1 year or older than 8 years
- Patients with ASA physical status III or higher
- Presence of acute infection signs
- History of previous nausea or vomiting
Where it is running
- Ankara Etlik City Hospital — Altındağ, Ankara, Turkey (Türkiye) (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.